Luis Ortega
Overview
Explore the profile of Luis Ortega including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
1349
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jimenez-Holguin J, Lozano D, Saiz-Pardo M, de Pablo D, Ortega L, Enciso S, et al.
Biomater Adv
. 2025 Jan;
169:214168.
PMID: 39756089
Local delivery of therapeutic ions from bioactive mesoporous glasses (MBGs) is postulated as one of the most promising strategies for regenerative therapy of critical bone defects. Among these ions, Sr...
2.
Garcia-Botella A, Martin P, Mendez R, Ortega L, Mendez J, Sastre J, et al.
HPB (Oxford)
. 2024 Feb;
26(4):603-605.
PMID: 38310081
No abstract available.
3.
Wilhelm A, Evans M, Xiong Z, Ortega L, Vock D, Maruyama G, et al.
Prev Sci
. 2024 Jan;
25(5):724-733.
PMID: 38244166
Adolescent school connectedness generally protects from risk behaviors such as tobacco use; however, its relationship to e-cigarette use is unclear. This study examines the relationship between adolescent school connectedness and...
4.
Jimenez-Holguin J, Arcos D, Lozano D, Saiz-Pardo M, de Pablo D, Ortega L, et al.
Int J Mol Sci
. 2022 Nov;
23(22).
PMID: 36430396
Zinc-enriched mesoporous bioactive glasses (MBGs) are bioceramics with potential antibacterial and osteogenic properties. However, few assays have been performed to study these properties in animal models. In this study, MBGs...
5.
Lopez-Ayala P, Alcaraz-Serna A, Valls Carbo A, Cuadrado Cenzual M, Torrejon Martinez M, Picado A, et al.
Emergencias
. 2022 Mar;
34(2):119-127.
PMID: 35275462
Objectives: Although many demographic and clinical predictors of mortality have been studied in relation to COVID-19, little has been reported about the prognostic utility of inflammatory biomarkers. Material And Methods:...
6.
Wilhelm A, Schwedhelm M, Bigelow M, Bates N, Hang M, Ortega L, et al.
BMC Public Health
. 2021 Sep;
21(1):1615.
PMID: 34479533
Background: Participatory research offers a promising approach to addressing health inequities and improving the social determinants of health for diverse populations of adolescents. However, little research has systematically explored factors...
7.
Gomez A, Pato M, Bujanda L, Sala N, Companioni O, Cosme A, et al.
Cancers (Basel)
. 2021 Jul;
13(11).
PMID: 34199386
To adopt prevention strategies in gastric cancer, it is imperative to develop robust biomarkers with acceptable costs and feasibility in clinical practice to stratified populations according to risk scores. With...
8.
Marquina G, Sanchez-Ramon S, Sarnago A, Ortega L, Bustos A, Hernando F, et al.
Case Rep Oncol
. 2021 Mar;
14(1):152-159.
PMID: 33776697
The vast majority of patients with soft tissue sarcomas (STS) of the trunk and bilateral lung metastases at diagnosis are considered incurable. These tumors have poor prognosis as only a...
9.
Martin-Sanchez F, Gonzalez Del Castillo J, Valls Carbo A, Picado A, Martinez-Valero C, Miranda J, et al.
Emergencias
. 2020 Jul;
32(4):242-252.
PMID: 32692001
Objectives: The primary objective was to describe the clinical characteristics and 30-day mortality rates in emergency department patients with coronavirus disease 2019 (COVID-19) in different diagnostic groupings. Material And Methods:...
10.
Martin-Sanchez F, Del Toro E, Cardassay E, Valls Carbo A, Cuesta F, Vigara M, et al.
Eur Geriatr Med
. 2020 Jul;
11(5):829-841.
PMID: 32671732
Purpose: To determine the differences by age-dependent categories in the clinical profile, presentation, management, and short-term outcomes of patients with laboratory-confirmed COVID-19 admitted to a Spanish Emergency Department (ED). Methods:...